IMARC Group, a leading market research company, has recently releases report titled “Epinephrine Autoinjector Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” The study provides a detailed analysis of the industry, including the global epinephrine autoinjector market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the epinephrine autoinjector market?
| Report Attributes | Details |
| Market Size in 2022 | US$ 2.2 Billion |
| Market Forecast in 2028 | US$ 3.4 Billion |
| Growth rate (2023 to 2028) | CAGR of 9.40% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
What is Epinephrine Autoinjector?
An epinephrine autoinjector represents a medical device specifically designed for the convenient administration of a single dose of epinephrine to treat severe allergic reactions caused by stings, insect bites, or medications. Its purpose is to deliver the drug directly into the thigh muscle, inducing constriction of blood vessels and dilation of the airways to alleviate the symptoms of an allergic reaction. In addition to this, the leading manufacturers are introducing epinephrine autoinjectors with multiple quantities of medicine and adjustable dosages. These advancements allow users to tailor the dosage according to the severity of the allergic reaction, thus enhancing treatment efficacy. As a result, this compact and portable device can be utilized by individuals or healthcare professionals.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/epinephrine-autoinjector-market/requestsample
What are the growth prospects and trends in the epinephrine autoinjector industry?
The escalating number of individuals experiencing allergies and allergic reactions, along with the increasing need for self-administration of medicines, is primarily driving the epinephrine autoinjector market. Besides this, the high prevalence of various conditions, such as arthritis, asthma, cancer, and chronic obstructive pulmonary disease (COPD), and the incorporation of audio and visual instructions into this device to facilitate its use in emergencies are further augmenting the market growth. Moreover, the launch of several policies by the government bodies to promote the use of epinephrine autoinjectors in schools and public spaces and the introduction of smart instruments integrated with advanced technologies, including Bluetooth connectivity, sensors, and machine learning (ML) to make them more convenient, user-friendly, and effective, are also catalyzing the global market. Apart from this, the development of mobile applications that allow for remote monitoring, tracking of usage and expiration dates, and ensuring that patients do not exceed recommended dosages is acting as another significant growth-inducing factor. Furthermore, the rising usage of automated external defibrillators (AED) to provide a comprehensive emergency response system is expected to bolster the epinephrine autoinjector market in the coming years.
Who are the key players operating in the industry?
The report covers the major market players including:
- Adamis Pharmaceuticals Corporation
- Amneal Pharmaceuticals Inc.
- Antares Pharma Inc
- Bausch Health
- Kaleo Inc.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Dosage:
- 0.15mg Epinephrine Autoinjector
- 0.3mg Epinephrine Autoinjector
- 0.5mg Epinephrine Autoinjector
Breakup by Application:
- Under 6 Years
- 6 to 12 Years
- Over 12 Years
Breakup by End User:
- Hospitals
- Clinics
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/epinephrine-autoinjector-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
